The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
The €70 million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing for biopharma customers, increasing annual output by several thousand tons
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12
Supply readiness follows months of manufacturing to ensure timely and ample supply
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
This product will be manufactured at Lupin's Pithampur facility in India
Subscribe To Our Newsletter & Stay Updated
